{"id":786,"date":"2025-06-16T00:10:00","date_gmt":"2025-06-15T22:10:00","guid":{"rendered":"https:\/\/www.dkcommunications.de\/en\/?p=786"},"modified":"2025-10-28T12:12:07","modified_gmt":"2025-10-28T11:12:07","slug":"dk-life-science-communications-gives-new-impetus-to-okedi-for-schizophrenia","status":"publish","type":"post","link":"https:\/\/www.dkcommunications.de\/en\/blog\/dk-life-science-communications-gives-new-impetus-to-okedi-for-schizophrenia\/","title":{"rendered":"dk Life Science Communications gives \u201cnew impetus to Okedi\u00ae\u201d for schizophrenia"},"content":{"rendered":"\n<p>\u201cCommunicating about mental illness requires sensitivity, specialist knowledge and experience &#8211; and that&#8217;s exactly what we bring to the table,\u201d says dk Managing Director Dr. Andreas Kloevekorn. \u201cWe are delighted about the trust placed in us and the task set by ROVI.\u201d<\/p>\n\n\n\n<p>With its novel galenics, the long-acting antipsychotic Okedi\u00ae is particularly suitable for modern schizophrenia therapy &#8211; a \u201cperfect match\u201d. The dk team is now using its expertise to communicate this knowledge in a catchy way and to activate the practitioners.<\/p>\n\n\n\n<p>The budget includes traditional PR, the development of target group-specific communication measures and, in particular, the expansion of digital activities: The agency is designing an online knowledge platform to bundle all content and measures.<\/p>\n\n\n\n<p>\u201cdk caught our interest with its strategic approach to further anchor Okedi\u00ae with new communicative impulses in the treatment of patients with schizophrenia,\u201d says Dr. Stefan Peters, Business Unit Director Psychiatry at Holzkirchen-based ROVI GmbH: \u201cThe mix of craftsmanship, consulting services and fresh ideas for storytelling and its implementation convinced us to work together.\u201d<\/p>\n\n\n\n<p>ROVI GmbH is the German branch of the internationally active Spanish pharmaceutical company Laboratorios Farmac\u00e9uticos ROVI, S.A., which specializes in innovative medicines.<\/p>\n\n\n\n<p><strong>About dk Life Science Communications&nbsp;<\/strong><\/p>\n\n\n\n<p>dk Life Science Communications has been one of the leading German communications agencies in the healthcare sector for over 30 years and is based in Frankfurt. The agency has been part of the WEFRA LIFE Group since 2023.&nbsp;<\/p>\n\n\n\n<p><strong>Media contact<\/strong><\/p>\n\n\n\n<p>Dr. Andreas Kloevekorn<br>dk Life Science Communications GmbH&nbsp;<br>Falkstrasse 5&nbsp;<br>60487 Frankfurt am Main&nbsp;<br>Phone: +49 69 61998-0&nbsp;<br>Fax: +49 69 61998-10&nbsp;<br>dkcommunications.com<\/p>\n","protected":false},"excerpt":{"rendered":"<p>dk Life Science Communications is delighted to welcome another new customer: The pharmaceutical company ROVI, manufacturer of the innovative drug Okedi\u00ae for the treatment of schizophrenia, is relying on the expertise of the Frankfurt-based healthcare specialists.<\/p>\n","protected":false},"author":3,"featured_media":787,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-786","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-allgemein"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.0 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>dk Life Science Communications gives \u201cnew impetus to Okedi\u00ae\u201d for schizophrenia - dk Life Science Communications<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.dkcommunications.de\/en\/blog\/dk-life-science-communications-gives-new-impetus-to-okedi-for-schizophrenia\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"dk Life Science Communications gives \u201cnew impetus to Okedi\u00ae\u201d for schizophrenia - dk Life Science Communications\" \/>\n<meta property=\"og:description\" content=\"dk Life Science Communications is delighted to welcome another new customer: The pharmaceutical company ROVI, manufacturer of the innovative drug Okedi\u00ae for the treatment of schizophrenia, is relying on the expertise of the Frankfurt-based healthcare specialists.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.dkcommunications.de\/en\/blog\/dk-life-science-communications-gives-new-impetus-to-okedi-for-schizophrenia\/\" \/>\n<meta property=\"og:site_name\" content=\"dk Life Science Communications\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-15T22:10:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-28T11:12:07+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/www.dkcommunications.de\/en\/wp-content\/uploads\/sites\/2\/2025\/06\/Rovi-.png\" \/>\n\t<meta property=\"og:image:width\" content=\"907\" \/>\n\t<meta property=\"og:image:height\" content=\"573\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"ohempel\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"ohempel\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.dkcommunications.de\/en\/blog\/dk-life-science-communications-gives-new-impetus-to-okedi-for-schizophrenia\/\",\"url\":\"https:\/\/www.dkcommunications.de\/en\/blog\/dk-life-science-communications-gives-new-impetus-to-okedi-for-schizophrenia\/\",\"name\":\"dk Life Science Communications gives \u201cnew impetus to Okedi\u00ae\u201d for schizophrenia - dk Life Science Communications\",\"isPartOf\":{\"@id\":\"https:\/\/www.dkcommunications.de\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.dkcommunications.de\/en\/blog\/dk-life-science-communications-gives-new-impetus-to-okedi-for-schizophrenia\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.dkcommunications.de\/en\/blog\/dk-life-science-communications-gives-new-impetus-to-okedi-for-schizophrenia\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.dkcommunications.de\/en\/wp-content\/uploads\/sites\/2\/2025\/06\/Rovi-.png\",\"datePublished\":\"2025-06-15T22:10:00+00:00\",\"dateModified\":\"2025-10-28T11:12:07+00:00\",\"author\":{\"@id\":\"https:\/\/www.dkcommunications.de\/en\/#\/schema\/person\/17ad51b5de09126d02da5a339b712266\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.dkcommunications.de\/en\/blog\/dk-life-science-communications-gives-new-impetus-to-okedi-for-schizophrenia\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.dkcommunications.de\/en\/blog\/dk-life-science-communications-gives-new-impetus-to-okedi-for-schizophrenia\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.dkcommunications.de\/en\/blog\/dk-life-science-communications-gives-new-impetus-to-okedi-for-schizophrenia\/#primaryimage\",\"url\":\"https:\/\/www.dkcommunications.de\/en\/wp-content\/uploads\/sites\/2\/2025\/06\/Rovi-.png\",\"contentUrl\":\"https:\/\/www.dkcommunications.de\/en\/wp-content\/uploads\/sites\/2\/2025\/06\/Rovi-.png\",\"width\":907,\"height\":573},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.dkcommunications.de\/en\/blog\/dk-life-science-communications-gives-new-impetus-to-okedi-for-schizophrenia\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\/\/www.dkcommunications.de\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"dk Life Science Communications gives \u201cnew impetus to Okedi\u00ae\u201d for schizophrenia\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.dkcommunications.de\/en\/#website\",\"url\":\"https:\/\/www.dkcommunications.de\/en\/\",\"name\":\"dk Life Science Communications\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.dkcommunications.de\/en\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.dkcommunications.de\/en\/#\/schema\/person\/17ad51b5de09126d02da5a339b712266\",\"name\":\"ohempel\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.dkcommunications.de\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/afb5eccb8da836894ad919195d7d9779?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/afb5eccb8da836894ad919195d7d9779?s=96&d=mm&r=g\",\"caption\":\"ohempel\"},\"url\":\"https:\/\/www.dkcommunications.de\/en\/blog\/author\/ohempel\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"dk Life Science Communications gives \u201cnew impetus to Okedi\u00ae\u201d for schizophrenia - dk Life Science Communications","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.dkcommunications.de\/en\/blog\/dk-life-science-communications-gives-new-impetus-to-okedi-for-schizophrenia\/","og_locale":"en_US","og_type":"article","og_title":"dk Life Science Communications gives \u201cnew impetus to Okedi\u00ae\u201d for schizophrenia - dk Life Science Communications","og_description":"dk Life Science Communications is delighted to welcome another new customer: The pharmaceutical company ROVI, manufacturer of the innovative drug Okedi\u00ae for the treatment of schizophrenia, is relying on the expertise of the Frankfurt-based healthcare specialists.","og_url":"https:\/\/www.dkcommunications.de\/en\/blog\/dk-life-science-communications-gives-new-impetus-to-okedi-for-schizophrenia\/","og_site_name":"dk Life Science Communications","article_published_time":"2025-06-15T22:10:00+00:00","article_modified_time":"2025-10-28T11:12:07+00:00","og_image":[{"width":907,"height":573,"url":"http:\/\/www.dkcommunications.de\/en\/wp-content\/uploads\/sites\/2\/2025\/06\/Rovi-.png","type":"image\/png"}],"author":"ohempel","twitter_card":"summary_large_image","twitter_misc":{"Written by":"ohempel","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.dkcommunications.de\/en\/blog\/dk-life-science-communications-gives-new-impetus-to-okedi-for-schizophrenia\/","url":"https:\/\/www.dkcommunications.de\/en\/blog\/dk-life-science-communications-gives-new-impetus-to-okedi-for-schizophrenia\/","name":"dk Life Science Communications gives \u201cnew impetus to Okedi\u00ae\u201d for schizophrenia - dk Life Science Communications","isPartOf":{"@id":"https:\/\/www.dkcommunications.de\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.dkcommunications.de\/en\/blog\/dk-life-science-communications-gives-new-impetus-to-okedi-for-schizophrenia\/#primaryimage"},"image":{"@id":"https:\/\/www.dkcommunications.de\/en\/blog\/dk-life-science-communications-gives-new-impetus-to-okedi-for-schizophrenia\/#primaryimage"},"thumbnailUrl":"https:\/\/www.dkcommunications.de\/en\/wp-content\/uploads\/sites\/2\/2025\/06\/Rovi-.png","datePublished":"2025-06-15T22:10:00+00:00","dateModified":"2025-10-28T11:12:07+00:00","author":{"@id":"https:\/\/www.dkcommunications.de\/en\/#\/schema\/person\/17ad51b5de09126d02da5a339b712266"},"breadcrumb":{"@id":"https:\/\/www.dkcommunications.de\/en\/blog\/dk-life-science-communications-gives-new-impetus-to-okedi-for-schizophrenia\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.dkcommunications.de\/en\/blog\/dk-life-science-communications-gives-new-impetus-to-okedi-for-schizophrenia\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.dkcommunications.de\/en\/blog\/dk-life-science-communications-gives-new-impetus-to-okedi-for-schizophrenia\/#primaryimage","url":"https:\/\/www.dkcommunications.de\/en\/wp-content\/uploads\/sites\/2\/2025\/06\/Rovi-.png","contentUrl":"https:\/\/www.dkcommunications.de\/en\/wp-content\/uploads\/sites\/2\/2025\/06\/Rovi-.png","width":907,"height":573},{"@type":"BreadcrumbList","@id":"https:\/\/www.dkcommunications.de\/en\/blog\/dk-life-science-communications-gives-new-impetus-to-okedi-for-schizophrenia\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/www.dkcommunications.de\/en\/"},{"@type":"ListItem","position":2,"name":"dk Life Science Communications gives \u201cnew impetus to Okedi\u00ae\u201d for schizophrenia"}]},{"@type":"WebSite","@id":"https:\/\/www.dkcommunications.de\/en\/#website","url":"https:\/\/www.dkcommunications.de\/en\/","name":"dk Life Science Communications","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.dkcommunications.de\/en\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.dkcommunications.de\/en\/#\/schema\/person\/17ad51b5de09126d02da5a339b712266","name":"ohempel","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.dkcommunications.de\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/afb5eccb8da836894ad919195d7d9779?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/afb5eccb8da836894ad919195d7d9779?s=96&d=mm&r=g","caption":"ohempel"},"url":"https:\/\/www.dkcommunications.de\/en\/blog\/author\/ohempel\/"}]}},"_links":{"self":[{"href":"https:\/\/www.dkcommunications.de\/en\/wp-json\/wp\/v2\/posts\/786"}],"collection":[{"href":"https:\/\/www.dkcommunications.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.dkcommunications.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.dkcommunications.de\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.dkcommunications.de\/en\/wp-json\/wp\/v2\/comments?post=786"}],"version-history":[{"count":1,"href":"https:\/\/www.dkcommunications.de\/en\/wp-json\/wp\/v2\/posts\/786\/revisions"}],"predecessor-version":[{"id":788,"href":"https:\/\/www.dkcommunications.de\/en\/wp-json\/wp\/v2\/posts\/786\/revisions\/788"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.dkcommunications.de\/en\/wp-json\/wp\/v2\/media\/787"}],"wp:attachment":[{"href":"https:\/\/www.dkcommunications.de\/en\/wp-json\/wp\/v2\/media?parent=786"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.dkcommunications.de\/en\/wp-json\/wp\/v2\/categories?post=786"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.dkcommunications.de\/en\/wp-json\/wp\/v2\/tags?post=786"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}